Deficit deepening of naive T-cells CD4+ in patients with HIV infection when co-infected with hepatitis C virus
https://doi.org/10.17238/PmJ1609-1175.2018.4.15-19
Abstract
About the Authors
K. V. ShmagelRussian Federation
L. B. Korolevskaya
Russian Federation
E. V. Saydakova
Russian Federation
N. G. Shmagel
Russian Federation
References
1. Работа выполнена при поддержке Комплексной программы УрО РАН; номер госрегистрации темы: АААА-А18-118030790046-9
2. Cianci R., Pinti M., Nasi M. [et al.]. Impairment of recent thymic emigrants in HCV infection // Int. J. Immunopathol. Pharmacol. 2005. Vol. 18, No. 4. P. 723-728.
3. Funderburg N., Luciano A.A., Jiang W. [et al.]. Toll-like receptor ligands induce human T cell activation and death, a model for HIV pathogenesis // PLoS One. 2008. Vol. 3. P. e1915.
4. Hartling H.J., Gaardbo J.C., Ronit A. [et al.]. Impaired thymic output in patients with chronic hepatitis C virus infection // Scand. J. Immunol. 2013. Vol. 78, No. 4. P. 378-386.
5. Hunt P.W, Sinclair E., Rodriguez B. [et al.]. Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection // J. Infect. Dis. 2014. Vol. 210, No. 8. P. 1228-1238.
6. Kohler S., Thiel A. Life after the thymus: CD31+ and CD31- human naive CD4+ T-cell subsets // Blood. 2009. Vol. 113, No. 4. P. 769-774.
7. Korolevskaya L.B., Shmagel K.V., Saidakova E.V. [et al.]. Effect of hepatitis C virus coinfection on the content of CD4(+) and CD8(+) T cell subpopulations in HIV-infected patients receiving antiretroviral therapy // Bull. Exp. Biol. Med. 2016. Vol. 161, No. 2. P. 281-283.
8. Potter M., Odueyungbo A., Yang H. [et al.]. Impact of hepatitis C viral replication on CD4+ T-lymphocyte progression in HIV-HCV coinfection before and after antiretroviral therapy // AIDS. 2010. Vol. 24. No. 12. P. 1857-1865.
9. Saidakova E.V., Korolevskaya L.B., Shmagel N.G. [et al.]. Role of hepatitis C virus coinfection in violation of productive thymic function in HIV-infected patients under immunologically inefficient antiretroviral therapy // Med. Immunology (Rus.). 2013. Vol. 15, No. 6. P. 543-552.
10. Santin M., Mestre M., Shaw E. [et al.]. Impact of hepatitis C virus coinfection on immune restoration during successful antiretroviral therapy in chronic human immunodeficiency virus type 1 disease // Eur. J. Clin. Microbiol. Infect. Dis. 2008. Vol. 27, No. 1. P. 65-73.
11. Shmagel K.V., Saidakova E.V., Shmagel N.G. [et al.]. Systemic inflammation and liver damage in HIV/hepatitis C virus coinfection // HIV Med. 2016. Vol. 17, No. 8. P. 581-589.
12. Taye S., Lakew M. Impact of hepatitis C virus co-infection on HIV patients before and after highly active antiretroviral therapy: an immunological and clinical chemistry observation, Addis Ababa, Ethiopia // BMC Immunol. 2013, Vol. 14. doi: 10.1186/1471-2172-14-23.
13. Yonkers N.L., Sieg S., Rodriguez B., Anthony D.D. Reduced naive CD4 T cell numbers and impaired induction of CD27 in response to T cell receptor stimulation reflect a state of immune activation in chronic hepatitis C virus infection // J. Infect. Dis. 2011. Vol. 203, No. 5. P. 635-645.
Review
For citations:
Shmagel K.V., Korolevskaya L.B., Saydakova E.V., Shmagel N.G. Deficit deepening of naive T-cells CD4+ in patients with HIV infection when co-infected with hepatitis C virus. Pacific Medical Journal. 2018;(4):15-19. (In Russ.) https://doi.org/10.17238/PmJ1609-1175.2018.4.15-19